Ruhr University Bochum
Bochum, North Rhine-Westphalia, 44787, Germany
NCT Number: NCT03780751
Problems with sexual function are common and distressing. The most frequent sexual difficulty in women is a lack of sexual desire with a prevalence of 20-30%. When low sexual desire is experienced over several months and causes significant personal distress, a sexual dysfunction can be diagnosed (ICD-10: Hypoactive Sexual Desire Disorder: HSDD). A distressing lack of desire is reported by 6% of sexually active women. Psychological interventions are the treatment of choice for women with HSDD. Promising treatment approaches include cognitive-behavioral and mindfulness-based interventions. A recent meta-analysis also showed that Internet-delivered programs are a valid alternative to face-to-face treatments. Aim of this project to assess the effectivity of two eight-week online-programs consisting of cognitive-behavioral (COPE) and mindfulness-based (MIND) interventions for women with HSDD. Both treatments will be compared to a waitlist-control group. For this project, two well-established group-treatment manuals will be translated into German and adapted to a multimedia online-environment. All participants will be guided through the programs by well-qualified eCoaches.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Bochum, North Rhine-Westphalia, 44787, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
COPE-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and cognitive-behavioral interventions (e.g., thought diaries, challenging of maladaptive thought patterns, behavioral analysis). Participants are encouraged to practice exercises between sessions.
MIND-program of 8 sessions (+ 1 booster session) of guided Internet-based treatment including psychoeducation, sexual education, guided masturbation, sensate focus and mindfulness-based exercises (e.g., breathing meditation, body scan, sitting meditation).
Time frame: at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
The SIDI-F is a clinician-rated instrument consisting of 13 items designed to assess HSDD severity in women. A self-report version, modified for the use in partnered and unpartnered women will be applied.
Time frame: at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
The Female Sexual Distress Scale (FSDS) is a 13-item self- assessment questionnaire for the evaluation of sexually related personal distress.
Time frame: at baseline, 5 weeks after baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
The Female Sexual Function Index measures women's sexual function with 19-items. Here, the two items assessing sexual desire will be used.
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 9-item self-report measure used to assess symptoms of depression.
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 7-item self-report measure used to assess symptoms of anxiety.
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 20-item self-report measure used to assess body awareness
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 15-item self-report measure used to assess mindfulness
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 15-item self-report measure used to assess body-related self-consciousness
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 12-item self-report scale used to assess self-compassion.
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
A 12-item scale that assess rumination about sexual issues
Time frame: at baseline, 3 months after baseline, 6 months after baseline, 12 months after baseline
Treatment adherence as measured with the HAPA scales
Time frame: 3 months after baseline, 6 months after baseline
Measures working alliance with eCoaches and online-program
Time frame: 3 months after baseline, 6 months after baseline
15-item self-report measure that assesses side-effects of psychological treatments
Time frame: 3 months after baseline, 6 months after baseline, 12 months after baseline
8-item self-report measure that assesses women's satisfaction with the online treatment they received
Time frame: at baseline, 3 months after baseline
An experimental paradigm used to assess implicit cognitive biases towards sexual stimuli
Time frame: at baseline, 3 months after baseline
An experimental paradigm used to assess implicit cognitive biases towards sexual stimuli
Time frame: 12 weeks after baseline
Qualitative telephone interviews with approx. 50 participants to assess perceived mechanisms of change as well as strengths and weaknesses of the programs
Ruhr University of Bochum
Other
Randomized-controlled Comparison of Two Online-interventions: How Effective Are Cognitive-behavioral and Mindfulness-based Sexual Therapy in Improving Sexual Desire in Women With Hypoactive Sexual Desire Disorder?
Acronym: MiSELF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04824820
Behavior, Cystitis
Los Angeles, California, United States
View Trial DetailsNCT03232801
Female Sexual Dysfunction, Genital Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT02430987
Body Weight, Genital Diseases
São Paulo, Brazil
View Trial DetailsNCT03287232
Genital Diseases, Hypoactive Sexual Desire Disorder
Huntsville, Alabama, United States
View Trial Details